Bumetanide and Drug toxicity - a phase IV clinical study of FDA data

Summary:

Drug toxicity is reported as a side effect among people who take Bumetanide (bumetanide), especially for people who are female, 60+ old, also take Warfarin Sodium, and have Osteoarthritis.

The phase IV clinical study analyzes which people have Drug toxicity when taking Bumetanide. It is created by eHealthMe based on reports of 20,353 people who have side effects when taking Bumetanide from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Drug toxicity?

Drug toxicity is found to be associated with 988 drugs and 1,385 conditions by eHealthMe. Check the latest studies of Drug toxicity.

On Jul, 07, 2026

20,353 people reported to have side effects when taking Bumetanide.
Among them, 24 people (0.12%) have Drug toxicity.

Among these 24 people:

What is the gender of people who have Drug toxicity when taking Bumetanide? *

female: 54.17 %
male: 45.83 %

What is the age of people who have Drug toxicity when taking Bumetanide? *

What are other drugs people take besides Bumetanide? *

What are other side effects people have besides Drug toxicity? *

Acute Kidney Failure: 7 people, 29.17%
Hyperkalemia (damage to or disease of the kidney): 4 people, 16.67%
Dehydration (dryness resulting from the removal of water): 4 people, 16.67%
Nausea And Vomiting: 4 people, 16.67%
Hypotension (abnormally low blood pressure): 4 people, 16.67%
Nausea (feeling of having an urge to vomit): 4 people, 16.67%
Diarrhea: 3 people, 12.50%
Drowsiness: 3 people, 12.50%
Confusional State: 3 people, 12.50%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 3 people, 12.50%

What are the existing conditions these people have? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 8.33%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 4.17%
Suicide Attempt: 1 person, 4.17%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 4.17%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.17%
Renal Impairment (severely reduced kidney function): 1 person, 4.17%
Pain: 1 person, 4.17%
Fever: 1 person, 4.17%
Cardiomyopathy (weakening of the heart muscle): 1 person, 4.17%
Cardiac Failure: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Drug toxicity?

- Check whether Drug toxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bumetanide:

Bumetanide (20,532 reports)

Drug toxicity treatments and more:

Drug toxicity (20,259 reports)

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug toxicity:

Drug toxicity (988 drugs)

Browse all the conditions that are associated with Drug toxicity:

Drug toxicity (1,385 conditions)

Related publications that referenced our studies

Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.